# A Phase IIa Study to Evaluate NBQ72S

Source: https://onco.cc/trials/nct06810804/  
OnCo record `nct06810804` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of NBQ72S in advanced solid tumours, run by Nantong Bencao Quadriga Medical Technology Co. Ltd., now recruiting.

## Summary

A Phase IIa Study to Evaluate NBQ72S is a phase 2 interventional study registered as NCT06810804 by Nantong Bencao Quadriga Medical Technology Co. Ltd., with 10 participants planned, started 2025-04-22 and due to reach its primary completion in 2026-08-31. Interventions recorded: NBQ72S.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06810804
- Phase: 2
- Setting: A Phase IIa Study to Evaluate the Efficacy and Safety of NBQ72S in Breast Cancer Patients With Leptomeningeal Metastases, With or Without Brain Parenchymal Metastases
- Sponsor: Nantong Bencao Quadriga Medical Technology Co. Ltd.
- Enrolled: 10

## Sources

- ClinicalTrials.gov NCT06810804: https://clinicaltrials.gov/study/NCT06810804

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct06810804.json